242 filings
Page 9 of 13
8-K
o00thrsh e6m9rgz0
31 Aug 18
Entry into a Material Definitive Agreement
12:00am
424B5
zifi13z4gezy5c2yf8k
31 Aug 18
Prospectus supplement for primary offering
12:00am
8-K
v2st0pihqjiy0
7 Aug 18
Reports Second Quarter 2018 Financial Results
5:10pm
8-K
oizxc74
1 Jun 18
Departure of Directors or Certain Officers
5:05pm
S-8
8qkfx
1 Jun 18
Registration of securities for employees
4:09pm
8-K
uychi84mu zsd8vdr6hy
30 May 18
CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug
4:37pm
8-K
pbk9xvj2a95rw
8 May 18
Reports First Quarter 2018 Financial Results
7:43am
DEFA14A
2a760n
18 Apr 18
Additional proxy soliciting materials
12:00am
8-K
egn 4oklckvt
8 Mar 18
Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
424B5
85h6uq2 dui1adgd
5 Jan 18
Prospectus supplement for primary offering
12:00am
8-K
ped66q0lc3wy299dnkvu
5 Jan 18
CRISPR Therapeutics Announces Proposed Public Offering of Common Shares
12:00am
424B5
ci046i0 0uhf6
3 Jan 18
Prospectus supplement for primary offering
12:00am
CT ORDER
3bi3w80f
21 Dec 17
Confidential treatment order
12:00am
8-K
si6ryv0ovz3sn9e kp
21 Dec 17
CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board
12:00am
8-K
iy8zqgqjk61 us
18 Dec 17
Vertex and CRISPR Therapeutics toCo-Develop andCo-Commercialize
12:00am